Previous close | 11,352.00 |
Open | 11,890.00 |
Bid | 11,054.00 x 0 |
Ask | 12,100.00 x 0 |
Day's range | 11,790.00 - 12,096.00 |
52-week range | 9,461.00 - 12,186.00 |
Volume | |
Avg. volume | 2,911,904 |
Market cap | 186.429B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 39.17 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (2.01%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease drugs.